Search results

Page results

• UCLH recruits first participant internationally for new trial in Frontotemporal dementia

  UCLH has recruited the first participant to an international trial in frontotemporal dementia (FTD), one of the most common causes of early-onset dementia.

• Brain changes in Huntington’s disease decades before diagnosis will guide future prevention trials

  Subtle changes in the brain, detectable through advanced imaging, blood and spinal fluid analysis, happen around twenty years before a clinical motor diagnosis in people with Huntington’s disease, a new study at UCLH and UCL has found.

• UCLH doctors take part in art workshops

  Last year, UCLH Arts & Heritage and our resident doctor community worked collaboratively to run a series of 10 creative workshops looking at various art-making methods aimed at improving the wellbeing of doctors.

• Thank you to the Islington Business Design Centre as the vaccination centre closes today

  After almost six months and more than 120,000 vaccinations the Islington Business Design Centre closes as a vaccination centre today (20 August 2021).

• Antibody treatment reduces risk of symptomatic COVID-19 by 77%

  An antibody treatment trialled at UCLH cuts the risk of developing symptomatic COVID-19 by 77%.

• Sir Keir Starmer visits Grafton Way Building

  Labour leader Sir Keir Starmer, who is also the MP for our local constituency, visited UCLH on Friday 3 September and was shown around the Grafton Way Building by our chief executive and chair.

• NHS patients to benefit from state-of-the-art diagnostic tests for Parkinson’s & Mitochondrial diseases, resulting from a UK-first partnership

  Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).

• Arif Ahmed, non-executive director

  Arif Ahmed is an entrepreneur and private equity investor in healthcare, technology, e-commerce and B2B services companies. He has a proven track record of scaling innovation in complex regulatory environments.

• Dr Jonathan Broomberg, non-executive director

  Dr Jonathan Broomberg joined the UCLH Board in January 2025 as a non-executive director. He is currently the CEO of Vitality Health International and Global Head of Health Insurance for the Discovery Group, bringing a wealth of experience in the commercial healthcare sector and global public health and policy.

• Proton Beam Therapy (PBT) in pictures

  Photo galleries of the PBT staff and facilities.